No results for ‘’
Prism Medico & Pharmacy Ltd
₹27.39
(1.48%)
Sat, 27 Jun 2026, 01:12 am
Finance
Financial Conglomerates
24.5KPrism Medico & Pharmacy PE Ratio
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Prism Medico & Pharmacy Ltd Price to Earnings Ratio
The Prism Medico & Pharmacy Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Prism Medico & Pharmacy Ltd's valuation, profitability, and overall financial performance. Tracking the Prism Medico & Pharmacy Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Prism Medico & Pharmacy Ltd (NSE: , BSE: 512217) is currently trading at ₹27.39, with a market capitalization of ₹16.61Cr. As a leading company in the Finance sector and Financial conglomerates industry, monitoring the Prism Medico & Pharmacy Ltd Price to Earnings Ratio is essential for fundamental analysis.
Prism Medico & Pharmacy Ltd Price to Earnings Ratio Current Value
The current Prism Medico & Pharmacy Ltd Price to Earnings Ratio stands at 0.
The Prism Medico & Pharmacy Ltd Price to Earnings Ratio remains stable, indicating consistent financial performance.
Prism Medico & Pharmacy Ltd Price to Earnings Ratio Historical Trend
The Prism Medico & Pharmacy Ltd Price to Earnings Ratio has shown the following historical trend:
The decline in Prism Medico & Pharmacy Ltd Price to Earnings Ratio indicates improving financial efficiency or better earnings growth.
What Prism Medico & Pharmacy Ltd Price to Earnings Ratio Indicates for Investors
The Prism Medico & Pharmacy Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.
A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.
Prism Medico & Pharmacy Ltd Price to Earnings Ratio Analysis Summary
The Prism Medico & Pharmacy Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Prism Medico & Pharmacy Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Prism Medico & Pharmacy Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.